Comparative statistics by cancer registry
Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
(Izmir, Turkey, 1995-1997 cases followed-up until 2003)Click on cancer site (ICD-10 code) for comparison
| Site | ICD-10 | No. of cases included | Complete FU | Incomplete FU: loss to FU | % with Complete FU at 5 years | Median FU (in months) | ||||||
| Alive/dead | At end of FU | No. | % | % lost to FU: years from diagnosis | ||||||||
| No. | % | <1 | 1-3 | 3-5 | >5 | |||||||
| C18 | Colon | 371 | 266 | 71.7 | 105 | 28.3 | 11.1 | 3.0 | 1.3 | 12.9 | 84.6 | 28.2 |
| C19-20 | Rectum | 344 | 232 | 67.5 | 112 | 32.5 | 16.0 | 2.9 | 2.0 | 11.6 | 79.1 | 24.6 |
| C32 | Larynx | 478 | 308 | 64.4 | 170 | 35.6 | 9.8 | 1.7 | 1.5 | 22.6 | 87.0 | 64.0 |
| C50 | Breast | 1329 | 806 | 60.7 | 523 | 39.3 | 10.9 | 2.3 | 1.8 | 24.3 | 85.0 | 72.0 |
| C53 | Cervix | 246 | 127 | 51.6 | 119 | 48.4 | 10.6 | 3.7 | 2.4 | 31.7 | 83.3 | 51.9 |
| C56 | Ovary | 230 | 141 | 61.3 | 89 | 38.7 | 10.9 | 1.3 | 2.6 | 23.9 | 85.2 | 49.6 |
| C67 | Urinary bladder | 566 | 350 | 61.8 | 216 | 38.2 | 13.3 | 2.7 | 1.2 | 21.0 | 82.9 | 49.3 |
| C81 | Hodgkin lymphoma | 85 | 56 | 65.8 | 29 | 34.2 | 11.8 | 5.9 | 1.2 | 15.3 | 81.1 | 65.0 |
| C82-85+C96 | Non-Hodgkin lymphoma | 344 | 256 | 74.5 | 88 | 25.5 | 11.6 | 3.2 | 2.0 | 8.7 | 83.2 | 22.4 |
| C90 | Multiple myeloma | 79 | 68 | 86.0 | 11 | 14.0 | 7.6 | 1.3 | 1.3 | 3.8 | 89.8 | 19.4 |
| C91 | Lymphoid leukaemia | 161 | 99 | 61.4 | 62 | 38.6 | 7.5 | 2.5 | 1.9 | 26.7 | 97.8 | 31.9 |
| C92-94 | Myeloid leukaemia | 148 | 119 | 80.3 | 29 | 19.7 | 6.8 | 4.1 | 2.0 | 6.8 | 87.1 | 16.9 |
Other tables available for this registry:
| - Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Izmir, Turkey, 1995-1997 cases followed-up until 2003) |
| - Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Izmir, Turkey, 1995-1997 cases followed-up until 2003) |
| - Table3: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Izmir, Turkey, 1995-1997 cases followed-up until 2003) |
| - Table4: | Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Izmir, Turkey, 1995-1997 cases followed-up until 2003) |
| - Table5b: | Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Izmir, Turkey, 1995-1997) |
Registry chapter:
 | Consult the chapter in Cancer survival in developping countries (Volume II) |